JATT II Acquisition Corp

Análisis de la acción JATT II Acquisition Corp (JATT)

$12.025

-0.099 (-0.82%)Al cierre

Loading chart…
High
12.000
Open
12.000
VWAP
12.01
Vol
5.61K
Mkt Cap
Low
12.000
Amount
67.34K
EV/EBITDA, TTM
0.00

JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue.

AI analysis of JATT II Acquisition Corp (JATT)

hold

Currently, Zura Bio Ltd (JATT) is not a strong buy due to its low RSI of 28.678, indicating it is oversold, and a 5-day change of -9.37%. However, it has shown a year-to-date change of +20.00%, suggesting potential for recovery. The main risk is the lack of earnings metrics, with a forward P/E of 0, indicating uncertainty in profitability.

Métricas de valoración

The current forward P/E ratio for JATT II Acquisition Corp (JATT) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

Whales holding JATT

C

Commodore Capital LP

+ HoldingJATT

+33.97%

3M Return

Cronología de eventos

2026-08-21 (ET)

10:00:00

Jatt II Acquisition Corp Trading Halted Due to Volatility

2026-06-29 (ET)

10:00:00

JATT II Acquisition Corp Ordinary Shares Trading Halted

07:30:00

Talawar Tx and JATT II to Merge, Expected to Raise $285 Million

2026-04-20 (ET)

11:30:00

AEVEX Opens Above $20 in IPO Debut

Noticias

JATT FAQ — answered by Alphio AI

JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue. It operates in the Financials sector.

Currently, Zura Bio Ltd (JATT) is not a strong buy due to its low RSI of 28.678, indicating it is oversold, and a 5-day change of -9.37%. However, it has shown a year-to-date change of +20.00%, suggesting potential for recovery. The main risk is the lack of earnings metrics, with a forward P/E of 0, indicating uncertainty in profitability.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis